Skip to content
★ Sign in to follow
Hironic Co., Ltd. logo

Hironic Co., Ltd. Stock: price and insider trades · South Korea

하이로닉

KR·Mcap ₩70BHealth Care

No insider purchase over the last 90 days. The latest, by 이진우, was filed 04 Aug 2026.

Hironic Co., Ltd.: what insiders have been doing

This page follows insider dealings at Hironic Co., Ltd. as filed with DART (FSS), a company from the Health Care sector. From 23 October 2025 to 23 October 2026, the disclosure feed for Hironic Co., Ltd. logged 7 filings by 2 insiders.

Purchases and sales both appear in the filings: 4 purchases (2 insiders) and 2 sales (1 insider). The totals exclude 6 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 1 chief executive.

Across the 2,650 companies tracked on its exchange, the median is 7 filings; at 7 filings, this issuer sits right on that mark. Since 2023, the database holds 11 purchases and 4 sales by insiders of the company.

The last insider purchase was made public on 4 August 2026, 96 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 5 days. The shorter that gap, the sooner other investors can see what insiders have done.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Insider Decl.
21
Thresholds
n/a
Buy Volume
€19M
11 ops. · all time
Sell Volume
€8M
4 ops. · all time

Who traded when

BuySale
이진우2 buys2 sales
캑터스웨스트뷰스페셜시츄에이션사모투자3 buys
Fundamental score
Ranked 9,424 of 26,914 companies
59.0
score / 100
Value
47
Quality
71
FCF yld-3.9%
Earn yld5.0%
EV/EBITDA10.7x
ROE6.3%
Gross mgn59%
Net mgn9.8%
Debt/EBITDA0.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩4,070
Analyst consensus
·
Income statement
Revenue₩32.1B
Gross profit₩18.9B59% margin
EBITDA₩6B19% margin
Net income₩3.2B12.2% margin
Valuation
Beta0.24
Balance sheet & cash
Market cap₩70B
Total debt₩1.4B
Free Cash Flow-₩2.5B
Debt / Equity0%
Profitability & ownership
ROE6.3%
ROA4.2%
% insiders61.1%
% institutions0.1%
Last declaration on 4 August 2026
Declarations21 total
  • ▲
    대표이사Executives(filed)
    €64kest.0DART
    21,271 sharesShareKRXDART:20260804000271
    Canonical exit: 2 Nov 2026 (T+90)
  • ▲
    €6.4Mest.0DART
    2,159,082 sharesKRXDART:20260128000463
    Canonical exit: 23 Apr 2026 (T+90)
  • ▲
    10%이상주주Executives(filed)
    0DART
    3,238,623 sharesShareKRXDART:20260128000470
    Canonical exit: 28 Apr 2026 (T+90)
  • ▼
    Executives
    €4.0Mest.0DART
    1,332,052 sharesKRXDART:20260127000404
  • ▼
    대표이사Executives(filed)
    €3.9Mest.0DART
    1,300,000 sharesShareKRXDART:20260127000205
  • ▲
    €3.2Mest.0DART
    1,079,541 sharesKRXDART:20251230000881
    Canonical exit: 23 Mar 2026 (T+90)
  • ●
    Executives
    Executives
    0DART
  • ▲
    사내이사Executives(filed)
    €65kest.0DART
    20,965 sharesShareKRXDART:20250408002834
    Canonical exit: 7 Jul 2025 (T+90)
  • ●
    Executives
    0DART
    0KRXDART:20241121000422
  • ●
    Executives
    0DART
    0KRXDART:20241112000408
  • ▲
    Executives
    €13kest.0DART
    2,921 sharesKRXDART:20241018000468
    Canonical exit: 12 Jan 2025 (T+90)
  • ●
    Executives
    0DART
    0KRXDART:20240910000122
  • ▼
    Executives
    €45kest.0DART
    9,002 sharesKRXDART:20240902000196
  • ▲
    Executives
    €4,958est.0DART
    1,000 sharesKRXDART:20240828000957
    Canonical exit: 21 Nov 2024 (T+90)
  • ▼
    Executives
    €8,463est.0DART
    1,200 sharesKRXDART:20240702000154
  • ▲
    Executives
    €5,744est.0DART
    1,000 sharesKRXDART:20240530001056
    Canonical exit: 21 Aug 2024 (T+90)
  • ▲
    대량보유자Executives
    €9.0Mest.0DART
    1,448,913 sharesKRXDART:20240313001460
    Canonical exit: 24 May 2024 (T+90)
  • ●
    사내이사Executives
    0DART
    ShareKRXDART:20231226000214
  • ●
    사내이사Executives
    0DART
    ShareKRXDART:20231201000212
  • ▲
    Executives
    €4,996est.0DART
    1,000 sharesKRXDART:20231130001026
    Canonical exit: 22 Feb 2024 (T+90)
  • ▲
    Executives
    €7,130est.0DART
    1,000 sharesKRXDART:20230830000832
    Canonical exit: 21 Nov 2023 (T+90)

21 of 21 declarations

About Hironic Co., Ltd.

하이로닉 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative technologies and products for health and wellness.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations